MedPath
HSA Approval

MEBETIN TABLET 135 mg

SIN09873P

MEBETIN TABLET 135 mg

MEBETIN TABLET 135 mg

July 9, 1998

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET, SUGAR COATED

ORAL

Medical Information

A03AA04

mebeverine

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

SAM CHUN DANG PHARM CO LTD

Active Ingredients

MEBEVERINE HCl

135 mg

Mebeverine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MEBETIN TABLET 135 mg - HSA Approval | MedPath